Visualizing Parkinson’s with Alpha-Synuclein PET Tracer to Determine Parkinson’s Disease Progression More Quantitatively
Time: 11:45 am
day: Conference Day One
Details:
Overviewing the landscape of alpha-synuclein PET tracer development: where
have we been and where are we now?
- Exploring the discovery/development, validation and implementation phases in clinical development to understand the requirements of each stage to translate effective PET tracers into clinically useful tools
